Surface Oncology, Inc. Quarterly Operating Income (Loss) in USD from Q1 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Surface Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2017 to Q2 2023.
  • Surface Oncology, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$25.6M, a 4.13% decline year-over-year.
  • Surface Oncology, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$89.4M, a 47.4% decline year-over-year.
  • Surface Oncology, Inc. annual Operating Income (Loss) for 2022 was -$61.9M, a 18.6% increase from 2021.
  • Surface Oncology, Inc. annual Operating Income (Loss) for 2021 was -$76M, a 223% decline from 2020.
  • Surface Oncology, Inc. annual Operating Income (Loss) for 2020 was $61.6M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$89.4M -$25.6M -$1.02M -4.13% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$88.4M -$19.7M -$26.5M -388% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 -$61.9M -$21.2M +$2.19M +9.37% Oct 1, 2022 Dec 31, 2022 8-K 2023-07-03
Q3 2022 -$64.1M -$22.9M -$3.41M -17.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 -$60.7M -$24.6M -$6.04M -32.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$54.6M $6.84M +$21.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$76M -$23.4M -$91.3M -134% Oct 1, 2021 Dec 31, 2021 8-K 2023-07-03
Q3 2021 $15.3M -$19.5M -$5.13M -35.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $20.5M -$18.6M -$4.05M -27.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $24.5M -$14.6M -$37.1M -165% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $61.6M $68M +$84.3M Oct 1, 2020 Dec 31, 2020 10-K 2021-03-09
Q3 2020 -$22.7M -$14.4M +$3.2M +18.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$25.9M -$14.5M +$3.97M +21.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$29.9M $22.5M +$27.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$57.4M -$16.3M -$10.8M -193% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 -$46.6M -$17.6M +$474K +2.63% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-09
Q2 2019 -$47.1M -$18.5M -$1.93M -11.6% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-09
Q1 2019 -$45.2M -$4.97M -$36M -116% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-09
Q4 2018 -$9.15M -$5.58M +$11.1M +66.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$20.2M -$18M -$3.76M -26.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-10
Q2 2018 -$16.4M -$16.6M -$10.1M -154% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-10
Q1 2018 -$6.39M $31M +$39.6M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
Q4 2017 -$46M -$16.6M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$14.3M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$6.53M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$8.55M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.